Excedrin PM Triple Action Caplets and Excedrin Tension Headache

Product NDC: 0067-8147
Requested package NDC: 0067-8147-01
11-digit product format: 000678147
Labeler code: 0067
Product ID: 0067-8147_5b0f5eff-6fa1-4334-a51c-fd79e54e209b
Type: HUMAN OTC DRUG
Nonproprietary name: Acetaminophen, Aspirin (NSAID), Caffeine, and Diphenhydramine Citrate
Dosage form: KIT
Labeler: Haleon US Holdings LLC
Application: M013
Marketing category: OTC MONOGRAPH DRUG
Marketing start: 2017-06-01
NDC exclude flag: No
Listing certified through: 2026-12-31
Current FDA listing: Yes

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 1 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Archive	Snapshot	Source SHA-256
2020-06-10 20:45 UTC · source 2020-06-10	excluded package	package	0067-8147	0067-8147-01	I	Inactivated by FDA		excluded / ndc_excluded.zip	`9bebd1f3094a…`	`5416666fcb17…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Additional Listing Data#

Finished product: Yes
Brand name base: Excedrin PM Triple Action Caplets and Excedrin Tension Headache
Listing expiration: 2026-12-31

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 4 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
307686	Internal RxNorm lookup
404172	Internal RxNorm lookup
1593110	Internal RxNorm lookup
1593116	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
978a9d27-6d41-42cb-a193-11314923d2ac	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
0e2e0f88-b076-afe1-4bdd-32bca4375bec	Product name	3	20250127
7dea7767-9f52-b60a-5435-33cb9cc28bae	Product name	4	20250124
6338270f-96cb-0ecb-6fbb-0a9bc78001f4	Product name	7	20250116
0ca83774-3f79-b837-5d6f-c210102f3bc8	Product name	6	20250114
41b814f3-0166-1c53-c9ef-a0794c7daf9d	Product name	3	20221110
a590be26-846c-8659-a5a1-fb25907965dc	Product name	2	20221110
d7724692-1155-4cc8-a415-22f5fc4aec35	Product name	6	20220216
c6f86816-7da6-43ea-8c25-ac9758311cc5	Product name	1	20220118
bde672ba-4805-28d0-1986-73543d41b412	Product name	2	20210201
2dc76302-91c0-4c35-ad78-99adfb049c4b	Product name	1	20200603
e6065d4b-5ae1-476f-a40e-f2851cbb5d2b	Product name	2	20180221
252e11b6-1a9a-4283-a242-df2c129c496d	Product name	3	20170717
f212291f-05fe-9603-fc7e-bd73e38ce1e6	Product name	2	20161129
ade821ba-260a-47e2-bd89-743e27ac9906	Product name	1	20161121
182f9ab4-4ab5-c449-200f-87ce2ce8e550	Product name	2	20151105
9425d234-4ae1-4b53-adc6-8cc7af6dd657	Product name	1	20150929
2a21311a-89e2-0e83-2ebd-117f9798b2b2	Product name	1	20140508
332e86c3-7875-ca6e-f934-2206d2b31996	Product name	1	20140508
3e48c9c4-918d-5d23-2f0b-d2398b06be54	Product name	1	20140508
56625fcc-aa34-9d30-d0e9-1c1beb37ea21	Product name	1	20140508
7dfac40f-a405-cd2e-7c06-3059ec0e1092	Product name	1	20140508
865c72dd-0d94-daac-f728-ddd4ded2a79e	Product name	1	20140508
9007e8a7-ff50-f9b9-7945-f2a1deadd94e	Product name	1	20140508
96c2be53-8e44-452d-56a2-d255b2f1af2d	Product name	1	20140508
bf8bd5f7-495f-4022-2780-7ded7ea7ea44	Product name	1	20140508
d223c173-c39b-d764-47d4-d671d3088815	Product name	1	20140508
e01133ad-4dcd-c7f3-454b-2ff569ee160a	Product name	1	20140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
0067-8147-01	2020-12-01	C162847	48780-1	9d75b9d0-c6f4-f424-e053-dadaa90a57ce	Drug Facts
0067-8147-01	2020-01-31	C162847	48780-1	9d75b9d0-c6f4-f424-e053-dadaa90a57ce	Drug Facts

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
0067-2056-24	Excedrin PM Triple Action Caplets and Excedrin Tension Headache	1 in 1 CARTON	TABLET, COATED		250 mg	5
0067-2056-24	Excedrin PM Triple Action Caplets and Excedrin Tension Headache	24 in 1 BOTTLE	TABLET, COATED	24	38 mg	5
0067-8139-02	Excedrin PM Triple Action Caplets and Excedrin Tension Headache	1 in 1 CARTON	TABLET, FILM COATED		65 mg	5
0067-8139-02	Excedrin PM Triple Action Caplets and Excedrin Tension Headache	100 in 1 BOTTLE	TABLET, FILM COATED	100	65 mg	5
0067-8147-01	Excedrin PM Triple Action Caplets and Excedrin Tension Headache	1 in 1 PACKAGE, COMBINATION	KIT	1		5

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
0067-8147	EXCEDRIN PM TRIPLE ACTION CAPLETS AND EXCEDRIN TENSION HEADACHE (ACETAMINOPHEN, ASPIRIN (NSAID), CAFFEINE, AND DIPHENHYDRAMINE CITRATE) KIT [HALEON US HOLDINGS LLC]	5	Current NDC, Legacy NDC, 5 package rows	20240316_978a9d27-6d41-42cb-a193-11314923d2ac.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 60 of 79 · 1,576 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Acetaminophen Regular Strength	ACETAMINOPHEN	United Natural Foods, Inc. dba UNFI	1462b308-a6a5-49ca-ab29-cacbf62caf0b	2024-10-17	Warnings	Exact identifier application number: M013
Acetaminophen Extra Strength	ACETAMINOPHEN	United Natural Foods, Inc. dba UNFI	f3db8598-fe0e-4c53-a023-5f5f8f002cc6	2024-10-17	Warnings	Exact identifier application number: M013
acetaminophen pm extra strength	ACETAMINOPHEN AND DIPHENHYDRAMINE HYDROCHLORIDE	United Natural Foods, Inc. dba UNFI	f86a11af-6d3c-4638-870d-a663ddf49371	2024-10-17	Warnings	Exact identifier application number: M013
Acetaminophen Gelcaps Extra Strength	ACETAMINOPHEN	United Natural Foods, Inc. dba UNFI	3588a3ef-a493-43ed-96e0-c259f0d087db	2024-10-17	Warnings	Exact identifier application number: M013
Pain Relief Extra Strength	ACETAMINOPHEN	STRATEGIC SOURCING SERVICES LLC	a2186895-944b-48cb-b3c2-eac208866c34	2024-10-17	Warnings	Exact identifier application number: M013
Pain Relief Regular Strength	ACETAMINOPHEN	STRATEGIC SOURCING SERVICES LLC	6a5d43c8-f4b7-4447-b2e1-53eb12208ef0	2024-10-17	Warnings	Exact identifier application number: M013
Enteric Coated Aspirin	ASPIRIN	STRATEGIC SOURCING SERVICES LLC	32cc6e05-84c1-4710-bebc-cb6e7133dc54	2024-10-17	Warnings	Exact identifier application number: M013
Aspirin	ASPIRIN	STRATEGIC SOURCING SERVICES LLC	2ca87a29-1f54-4da4-a66f-3b3dd4f0396c	2024-10-17	Warnings	Exact identifier application number: M013
Pain Relief Extra Strength	ACETAMINOPHEN	STRATEGIC SOURCING SERVICES LLC	9f0aef5d-20b0-469d-a58d-1cbf83a0dd8e	2024-10-17	Warnings	Exact identifier application number: M013
Aspirin	ASPIRIN	Kroger Company	453f62d5-f580-4d19-bfae-4f78c2a6b6d6	2024-10-16	Warnings	Exact identifier application number: M013
Acetaminophen Extra Strength	ACETAMINOPHEN	FSA Store Inc.	ec6add55-f4a3-7818-e053-2a95a90aee04	2024-10-16	Warnings	Exact identifier application number: M013
ASPIRIN	ASPIRIN	FSA Store Inc.	062e7b7b-d052-82b0-e063-6294a90a7cce	2024-10-16	Warnings	Exact identifier application number: M013
Acetaminophen PM	ACETAMINOPHEN AND DIPHENHYDRAMINE HYDROCHLORIDE	FSA STORE INC.	f4322f34-ac19-371e-e053-2a95a90ac864	2024-10-16	Warnings	Exact identifier application number: M013
Low dose Chewable Aspirin	ASPIRIN	FSA STORE INC.	f939b44c-93b6-ca61-e053-6394a90ae586	2024-10-16	Warnings	Exact identifier application number: M013
Pain Relief	ACETAMINOPHEN	DISCOUNT DRUG MART	850b5ad8-8774-413c-ae38-022215a94f95	2024-10-16	Warnings	Exact identifier application number: M013
LOW DOSE ASPIRIN	ASPIRIN	DISCOUNT DRUG MART	af0f50d2-3e2d-f723-e053-2995a90a0d4b	2024-10-16	Warnings	Exact identifier application number: M013
Enteric Coated Aspirin	ASPIRIN	DISCOUNT DRUG MART	03ed19dd-1cfc-47d5-b83e-ffa2ebe93f48	2024-10-16	Warnings	Exact identifier application number: M013
PAIN RELIEF Regular Strength	ACETAMINOPHEN	AMERICAN SALES COMPANY	2e3eabc8-193b-4397-a43c-db838eb16e67	2024-10-15	Warnings	Exact identifier application number: M013
Chewable Aspirin	ASPIRIN	RETAIL BUSINESS SERVICES , LLC.	c94d68ea-7f25-881f-e053-2995a90aa47f	2024-10-15	Warnings	Exact identifier application number: M013
LOW DOSE ASPIRIN	ASPIRIN	RETAIL BUSINESS SERVICES , LLC.	c94d750e-5a85-77f5-e053-2995a90a6915	2024-10-15	Warnings	Exact identifier application number: M013

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
1593110	acetaminophen 250 MG / aspirin 250 MG / diphenhydrAMINE citrate 38 MG Oral Tablet	PSN	978a9d27-6d41-42cb-a193-11314923d2ac	5
307686	acetaminophen 500 MG / caffeine 65 MG Oral Tablet	PSN	978a9d27-6d41-42cb-a193-11314923d2ac	5
1593116	Excedrin PM Triple Action (250 MG / 250 MG / 38 MG) Oral Tablet	PSN	978a9d27-6d41-42cb-a193-11314923d2ac	5
404172	EXCEDRIN TENSION HEADACHE 500 MG / 65 MG Oral Tablet	PSN	978a9d27-6d41-42cb-a193-11314923d2ac	5
1593116	acetaminophen 250 MG / aspirin 250 MG / diphenhydramine citrate 38 MG Oral Tablet [Excedrin PM Triple Action]	SBD	978a9d27-6d41-42cb-a193-11314923d2ac	5
404172	acetaminophen 500 MG / caffeine 65 MG Oral Tablet [Excedrin Tension Headache]	SBD	978a9d27-6d41-42cb-a193-11314923d2ac	5
1593110	acetaminophen 250 MG / aspirin 250 MG / diphenhydramine citrate 38 MG Oral Tablet	SCD	978a9d27-6d41-42cb-a193-11314923d2ac	5
307686	acetaminophen 500 MG / caffeine 65 MG Oral Tablet	SCD	978a9d27-6d41-42cb-a193-11314923d2ac	5
1593110	APAP 250 MG / ASA 250 MG / Diphenhydramine Citrate 38 MG Oral Tablet	SY	978a9d27-6d41-42cb-a193-11314923d2ac	5
1593116	APAP 250 MG / ASA 250 MG / Diphenhydramine Citrate 38 MG Oral Tablet [Excedrin PM Triple Action]	SY	978a9d27-6d41-42cb-a193-11314923d2ac	5
307686	APAP 500 MG / Caffeine 65 MG Oral Tablet	SY	978a9d27-6d41-42cb-a193-11314923d2ac	5
404172	APAP 500 MG / Caffeine 65 MG Oral Tablet [Excedrin Tension Headache]	SY	978a9d27-6d41-42cb-a193-11314923d2ac	5
404172	Excedrin Aspirin Free (acetaminophen 500 MG / caffeine 65 MG) Oral Tablet	SY	978a9d27-6d41-42cb-a193-11314923d2ac	5
1593116	Excedrin PM Triple Action (acetaminophen 250 MG / aspirin 250 MG / diphenhydramine citrate 38 MG) Oral Tablet	SY	978a9d27-6d41-42cb-a193-11314923d2ac	5
404172	Excedrin Tension Headache (APAP 500 MG / caffeine 65 MG) Oral Tablet	SY	978a9d27-6d41-42cb-a193-11314923d2ac	5

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
0067-8147-01	00067814701	1 KIT in 1 PACKAGE, COMBINATION (0067-8147-01) * 1 BOTTLE in 1 CARTON (0067-2056-24) / 24 TABLET, COATED in 1 BOTTLE * 1 BOTTLE in 1 CARTON (0067-8139-02) / 100 TABLET, FILM COATED in 1 BOTTLE	1 kit	2017-06-01	0000-00-00	No	No	Current